• Skip to primary navigation
  • Skip to main content

IMMUNOLOGY2024™

May 3–7, 2024 | Chicago, Illinois

  • Policies
  • Program
    • President’s Program
    • Distinguished Lectures
    • Major Symposia
    • Special Session
    • Committee Sponsored Sessions
    • Block Symposia
    • Poster Sessions
    • Award Presentations & Lectures
    • Career Development Sessions
    • Guest Sessions
    • AAI Business Meeting
    • Exhibitor Workshops
    • Social Events
  • Register
    • Registration FAQ
  • Hotels
  • Awards
  • Careers
    • For Job Seekers
    • For Employers
    • Jobs Board
  • Abstracts
    • Abstract FAQ
    • Submission Tips
    • Podium Presentation Guidelines
    • Poster Presentation Guidelines
    • Abstract Topic Categories
    • Major Symposium Guidance for Trainees
    • Abstract Policies and Procedures
    • Program Acknowledgements
  • Exhibitors
  • Sponsors
  • Resources
    • Attendee Social Media Toolkit
    • Presenter Social Media Toolkit
    • Podium Presentation Guidelines
    • Poster Presentation Guidelines
  • FAQ
    • General FAQ
    • Abstract FAQ
    • Registration FAQ
  • Show Search
Hide Search
 Sunday, May 5, 2024     12:45 PM – 2:15 PM ET     Room W185

National Cancer Institute (NCI), NIH Symposium

Mechanisms of Immune-related Adverse Events in Cancer Immunotherapy

Chairs
Yin Liu, NCI, NIH, USA
Alexandra Chloe Villani, Massachusetts Gen. Hosp., USA

Speakers
Alexandra Chloe Villani, Massachusetts Gen. Hosp., USA, Learning the mechanisms of immune tolerance through the lenses of irAE to immunotherapy
Roza Nurieva, Univ. of Texas MD Anderson Cancer Ctr., USA, Preclinical models of irAE: mechanistic insights and potential targets
Arabella Young, Univ. of Utah, USA, Improving the safety and efficacy of immune checkpoint inhibitors with syngeneic tumors in autoimmune-prone mice

AAI Logo

Footer

IMMUNOLOGY2024™

May 3–7, 2024
McCormick Place
Chicago, Illinois, USA

Copyright © 2025 The American Association of Immunologists. All rights reserved.